J Biol Chem 2006, 281:1771–1777 CrossRefPubMed

23 Chesne

J Biol Chem 2006, 281:1771–1777.CrossRefPubMed

23. Chesnel L, Carapito R, Croize J, Dideberg O, Vernet T, Zapun A: Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with Selleck Sapanisertib different levels of beta-lactam resistance. Antimicrob Agents Chemother 2005, 49:2895–2902.CrossRefPubMed 24. Contreras-Martel C, Job V, Di Guilmi AM, Vernet T, Dideberg O, Dessen A: Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae. J Mol Biol 2006, Selleckchem PF 2341066 355:684–696.CrossRefPubMed 25. Dessen A, Mouz N, Gordon E, Hopkins J, Dideberg O: Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations. J Biol Chem 2001, 276:45106–45112.CrossRefPubMed 26. Gordon E, Mouz N, Duee E, Dideberg O: The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and

its acyl-enzyme form: implication in drug resistance. J Mol Biol 2000, 299:477–485.CrossRefPubMed 27. Grebe T, Hakenbeck R: Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics. Antimicrob Agents Chemother PD0332991 1996, 40:829–834.PubMed 28. Smith AM, Klugman KP: Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1995, 39:859–867.PubMed 29. Smith AM, Klugman KP: Site-specific mutagenesis analysis of PBP 1A from a penicillin-cephalosporin-resistant

pneumococcal isolate. Antimicrob Agents Chemother 2003, 47:387–389.CrossRefPubMed 30. Smith AM, Klugman KP: Amino acid mutations essential to production of an altered PBP 2X conferring high-level beta-lactam resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother 2005, 49:4622–4627.CrossRefPubMed 31. Echenique J, Kadioglu A, Romao S, Andrew PW, Trombe MC: Protein serine/threonine kinase StkP positively controls virulence and competence in Streptococcus pneumoniae. Infect Immun 2004, 72:2434–2437.CrossRefPubMed 32. Pallova P, Hercik K, Saskova L, Novakova L, Branny Dimethyl sulfoxide P: A eukaryotic-type serine/threonine protein kinase StkP of Streptococcus pneumoniae acts as a dimer in vivo. Biochem Biophys Res Commun 2007,355(2):526–530.CrossRefPubMed 33. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, et al.: Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 2008, 205:117–131.CrossRefPubMed 34. Yeats C, Finn RD, Bateman A: The PASTA domain: a beta-lactam-binding domain. Trends Biochem Sci 2002, 27:438.CrossRefPubMed 35.

Comments are closed.